البلد: أستراليا
اللغة: الإنجليزية
المصدر: Department of Health (Therapeutic Goods Administration)
Foeniculum vulgare, Quantity: 22.2 mg (Equivalent: Foeniculum vulgare, Qty 133.2 mg); Zingiber officinale, Quantity: 22.2 mg (Equivalent: Zingiber officinale, Qty 133.2 mg); Rehmannia glutinosa, Quantity: 44.7 mg (Equivalent: Rehmannia glutinosa, Qty 268.2 mg); Cinnamomum cassia, Quantity: 22.2 mg (Equivalent: Cinnamomum cassia, Qty 133.2 mg; Equivalent: coumarin, Qty 2.1 microgram); Wolfiporia cocos, Quantity: 44.4 mg (Equivalent: Wolfiporia cocos, Qty 266.4 mg); Paeonia suffruticosa, Quantity: 33.3 mg (Eq
Sun Herbal Pty Ltd
Alisma plantago aquatica,Cinnamomum cassia,Cornus officinalis,Dioscorea oppositifolia,Foeniculum vulgare,Paeonia suffruticosa,Po
Capsule, hard
Excipient Ingredients: hydrolysed gelatin; titanium dioxide; soluble maize starch
Oral
Medicine Listed
Traditionally used in Chinese medicine to tonify/nourish/strengthen/replenish kidneys/kidney-qi ; Traditionally used in Chinese medicine to warm and nourish/strenghten/tonify/enrich kidneys/kidney-yang
Visual Identification: ;
Listed
NAPROSYN SR ® N A P R O S Y N S R ® CONSUMER MEDICINE INFORMATION (CMI) SUMMARY The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. 1. WHY AM I USING NAPROSYN SR? NAPROSYN SR contains the active ingredient naproxen. NAPROSYN SR is used to relieve pain and reduces inflammation (swelling, redness and soreness) that may occur in different types of arthritis including rheumatoid arthritis, osteoarthritis and ankylosing spondylitis. For more information, see Section 1. Why am I using NAPROSYN SR? in the full CMI. 2. WHAT SHOULD I KNOW BEFORE I USE NAPROSYN SR? Do not use if you have ever had an allergic reaction to naproxen, aspirin or any other NSAID medicines, or any of the ingredients listed at the end of the CMI. TALK TO YOUR DOCTOR IF YOU HAVE ANY OTHER MEDICAL CONDITIONS, TAKE ANY OTHER MEDICINES, OR ARE PREGNANT OR PLAN TO BECOME PREGNANT OR ARE BREASTFEEDING. For more information, see Section 2. What should I know before I use NAPROSYN SR? in the full CMI. 3. WHAT IF I AM TAKING OTHER MEDICINES? Some medicines may interfere with NAPROSYN SR and affect how it works. A list of these medicines is in Section 3. What if I am taking other medicines? in the full CMI. 4. HOW DO I USE NAPROSYN SR? • Your doctor will tell you how many NAPROSYN SR tablets to take each day. The usual dose is one tablet once a day. • More instructions can be found in Section 4. How do I use NAPROSYN SR? in the full CMI. 5. WHAT SHOULD I KNOW WHILE USING NAPROSYN SR? THINGS YOU SHOULD DO • Remind any doctor, dentist or pharmacist you visit that you are using NAPROSYN SR. • Tell your doctor if you get an infection while using NAPROSYN SR. • Tell your doctor if you feel the tablets are not helping your condition. • Call your doctor straight away if you become pregnant while taking NAPROSYN SR. THINGS YOU SHOULD NOT DO • Do not give NAPROSYN SR to anyone else, even if they have the same condition as you. • Do not use NAPROSYN SR to treat other compl اقرأ الوثيقة كاملة
1 AUSTRALIAN PRODUCT INFORMATION – NAPROSYN ® SR (NAPROXEN) 1. NAME OF THE MEDICINE naproxen 2. QUALITATIVE AND QUANTITATIVE COMPOSITION NAPROYSN SR 750 is available as a sustained release tablet containing 750 mg of naproxen. NAPROYSN SR 1000 is available as a sustained release tablet containing 1000 mg of naproxen. For the full list of excipients, see Section 6.1 LIST OF EXCIPIENTS. 3. PHARMACEUTICAL FORM NAPROYSN SR 750 sustained release tablets are available as a peach-coloured capsule-shaped tablet debossed with NPR SR-750 on one side. NAPROYSN SR 1000 sustained release tablets are available as a peach-coloured oblong tablet, debossed NPR SR-1000 on one side. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS NAPROSYN SR is indicated for the treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis and for the relief of chronic pain states in which there is an inflammatory component. 4.2 DOSE AND METHOD OF ADMINISTRATION After assessing the risk/benefit ratio in each individual patient, the lowest effective dose for the shortest possible duration should be used. The total required daily dose of naproxen can be achieved by the administering the appropriate single daily dose i.e. NAPROSYN SR 750 mg or NAPROSYN SR 1000 mg. The total daily dose of naproxen should not exceed 1000 mg. NAPROSYN SR tablets should be taken whole and not chewed. NAPROSYN SR TABLETS ARE NOT INTENDED FOR PATIENTS REQUIRING SHORT-TERM TREATMENT FOR ACUTE INDICATIONS. Patients on long term treatment should be reviewed regularly with regards to efficacy, risk factors and ongoing need for treatment. PREGNANCY See Section 4.6 FERTILITY, PREGNANCY AND LACTATION. 4.3 CONTRAINDICATIONS NAPROSYN SR is contraindicated in patients: • who are hypersensitive to naproxen or naproxen sodium or in whom acetylsalicylic acid (aspirin) or other non-steroidal anti-inflammatory/analgesic agents induce allergic manifestations, e.g. asthma, nasal polyps, rhinitis and urticaria. Severe anaphylactic-like reactions to naproxen have been rep اقرأ الوثيقة كاملة